GlassScriptPhysician profile
Sion K Roy
NPI 1245499656
$6,047.47
in general payments reported to CMS, 2019-2025
16 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $33.22 · 2021: $161 · 2022: $139 · 2023: $4,680 · 2024: $516 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,355 · Food and Beverage: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,355.00 |
| Food and Beverage | $994.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arineta, INC | $4,355.00 | 2023 | Spotlight |
| Boston Scientific Corporation | $735.94 | 2022-2025 | Rotapro, Avvigo Guidance System, Mamba |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.40 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $108.55 | 2019-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $98.38 | 2019-2021 | |
| Amgen INC. | $85.75 | 2019-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $84.98 | 2019-2024 | |
| Pfizer INC. | $79.27 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $75.93 | 2023-2024 | Camzyos |
| Heartflow, INC. | $57.73 | 2022 | |
| Novo Nordisk INC | $46.18 | 2021-2022 | |
| Scpharmaceuticals INC. | $44.22 | 2024 | |
| Astellas Pharma US INC | $40.05 | 2019 | |
| Philips North America LLC | $20.33 | 2022 | |
| Abbott Laboratories | $19.63 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $16.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sion Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.